8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis

Clinical trial NCT03186365 · COMPLETED

Trial details

NCT number: NCT03186365
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2017-06-12
Primary completion: 2018-09-19
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.